Get the Stockscreener App
48.03
2.67%
1.2182
Tempus Ai Inc stock is traded at $48.03, with a volume of 2.26M.
It is up +2.67% in the last 24 hours and down -8.03% over the past month.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
See More
Previous Close:
$46.81
Open:
$50.17
24h Volume:
2.26M
Relative Volume:
0.43
Market Cap:
$8.58B
Revenue:
$1.27B
Net Income/Loss:
$-245.03M
P/E Ratio:
-34.14
EPS:
-1.4071
Net Cash Flow:
$-245.36M
1W Performance:
+2.20%
1M Performance:
-8.03%
6M Performance:
-53.45%
1Y Performance:
+29.10%
1-Day Range:
$47.57
$50.81
1-Week Range:
$44.13
$50.81
52-Week Range:
$36.22
$104.32
Tempus Ai Inc Stock (TEM) Company Profile
Name
Tempus Ai Inc
Sector
Industry
Phone
800-976-5448
Address
600 WEST CHICAGO AVENUE, CHICAGO
Compare TEM vs VEEV, BTSG, HQY, WAY
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TEM
Tempus Ai Inc
|
47.99 | 8.37B | 1.27B | -245.03M | -245.36M | -1.4071 |
VEEV
Veeva Systems Inc
|
173.62 | 28.18B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
45.73 | 8.43B | 12.91B | 104.80M | 394.69M | 0.8769 |
HQY
Healthequity Inc
|
81.92 | 6.85B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
23.04 | 4.38B | 1.10B | 112.09M | 283.19M | 0.6096 |
Tempus Ai Inc Stock (TEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-19-26 | Initiated | Mizuho | Outperform |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-21-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-20-25 | Initiated | Canaccord Genuity | Buy |
| Sep-02-25 | Initiated | H.C. Wainwright | Buy |
| Apr-21-25 | Initiated | BTIG Research | Buy |
| Feb-25-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-12-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Feb-05-25 | Resumed | TD Cowen | Buy |
| Dec-13-24 | Initiated | Wolfe Research | Outperform |
| Dec-09-24 | Initiated | Guggenheim | Buy |
| Nov-11-24 | Downgrade | Stifel | Buy → Hold |
| Oct-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-12-24 | Initiated | Piper Sandler | Neutral |
| Jul-09-24 | Initiated | BofA Securities | Buy |
| Jul-09-24 | Initiated | JP Morgan | Overweight |
| Jul-09-24 | Initiated | Longbow | Buy |
| Jul-09-24 | Initiated | Loop Capital | Buy |
| Jul-09-24 | Initiated | Morgan Stanley | Overweight |
| Jul-09-24 | Initiated | Needham | Buy |
| Jul-09-24 | Initiated | Stifel | Buy |
| Jul-09-24 | Initiated | TD Cowen | Buy |
| Jul-09-24 | Initiated | William Blair | Outperform |
View All
Tempus Ai Inc Stock (TEM) Latest News
InvestingPro’s Fair Value spotted Tempus AI’s 39% decline in advance By Investing.com - Investing.com South Africa
Tempus AI (TEM) plans 2026 virtual meeting, auditor and pay votes - Stock Titan
What's Fueling the Strong Expansion of TEM Data and Applications Arm? - Bitget
What's Driving TEM Data and Applications Arm's Robust Growth? - Yahoo Finance
Artificial Intelligence Stocks To ResearchApril 7th - MarketBeat
Artificial Intelligence Stocks To Watch TodayApril 6th - MarketBeat
Buy Signal: How does Tempus AI Inc correlate with Nasdaq2026 Short Interest & Expert Curated Trade Setups - baoquankhu1.vn
Signal Recap: Whats next for Tempus AI Inc stock2026 Movers & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Tempus AI, Inc. (NASDAQ:TEM) Q1 2025 Earnings Call Transcript - MSN
Cathie Wood Chooses Medical AI Over Mark Zuckerberg: Ark Loads Up On TEM Stock, Dumps Meta Shares - AOL.com
Top Artificial Intelligence Stocks To Watch NowApril 5th - MarketBeat
Tempus AI: A Stock Caught Between Institutional Backing and Market Skepticism - AD HOC NEWS
Best Artificial Intelligence Stocks To Add to Your WatchlistApril 4th - marketbeat.com
Tempus AI stock gains following the ALERT trial result announcement - msn.com
Tempus AI, Inc. (TEM) stock price, news, quote and history - Yahoo Finance UK
Best Artificial Intelligence Stocks To Keep An Eye OnApril 3rd - MarketBeat
Tempus AI: A Dual-Engine AI Model - Seeking Alpha
Tempus, Medtronic find AI alert tool can improve cardiac valve care - Crain's Chicago Business
Tempus AI, Inc. (TEM) Stock Price, News, Quote & History - Yahoo! Finance Canada
List of 5 Acquisitions by Tempus (Apr 2026) - Tracxn
Tempus AI Shares Rise After ALERT Trial Results Are Revealed - Bitget
Tempus AI Stock Gains Following the ALERT Trial Result Announcement - Yahoo Finance
Suits Against Tempus AI Test Legal Lines for Mining Genetic Data - Law.com
DLD Asset Management, LP's Tempus AI Inc(TEM) Holding History - gurufocus.com
TEM Stock Price, Quote & Chart | TEMPUS AI INC-CL A (NASDAQ:TEM) - ChartMill
Assessing Tempus AI (TEM) Valuation After ALERT Cardiology Trial Results And Expanded Merck Collaboration - Yahoo Finance
Tempus AI: 450-Petabyte Moat, High-Growth Upside At A Discount (NASDAQ:TEM) - Seeking Alpha
Can Tempus AI’s (TEM) ALERT Trial Quietly Redefine Its Real-World Data Advantage in Cardiology? - Yahoo Finance
Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease - 01net
What's Fueling TEM Diagnostics Segment's Strong 2026 Outlook? - finance.yahoo.com
Tempus AI Stock Jumps, ALERT Trial Results Boost EHR Automation BuzzTempus AI (NASDAQ:TEM) - Benzinga
Tempus AI, Inc. Announces Results from ALERT Trial - marketscreener.com
Tempus AI, Medtronic Report Positive Clinical Trial Results for Medical Alert System - MarketScreener
Tempus and Medtronic announce alert trial results showing AI-driven EHR notifications improve treatment for significant valvular heart disease - marketscreener.com
Tempus And Medtronic Announce Alert Trial Results Showing Ai-Driven Ehr Notifications Improve Treatment For Significant Valvular Heart Disease - TradingView
Tempus AI trial shows automated alerts improve heart valve care By Investing.com - Investing.com India
Tempus AI trial shows automated alerts improve heart valve care - Investing.com
TEM vs. DOCS: Which Medical Info Systems Stock Is the Better Pick Now? - The Globe and Mail
Jim Cramer on Tempus AI: “It’s a Decent Spec, I Would Hold on to Some, But Not All” - Insider Monkey
Hims & Hers Expands Personalized Digital Healthcare Platform - TradingView
2 AI Healthcare Stocks to Buy Right Now - The Globe and Mail
Tempus AI, Inc.Class A Common Stock (NQ: TEM - FinancialContent
Tempus AI: An Attractive Entry Point At Current Prices (NASDAQ:TEM) - Seeking Alpha
Tempus AI (TEM) Analyst Rating Update: Guggenheim Lowers Price T - GuruFocus
Buy, sell, or hold? Jim Cramer’s take on 18 callers’ stocks as crude oil prices climb - MSN
Guggenheim Has Lowered Expectations for Tempus AI (NASDAQ:TEM) Stock Price - MarketBeat
Guggenheim Maintains Tempus AI(TEM.US) With Buy Rating, Cuts Target Price to $60 - Moomoo
Tempus AI Insider Sold Shares Worth $7,711,150, According to a Recent SEC Filing - MarketScreener
Tempus AI, Inc. (F3M.SG) Analyst insights, Price targets and Recommendations - Yahoo Finance Singapore
Top Artificial Intelligence Stocks To Follow TodayMarch 29th - marketbeat.com
TEM Stock Quote Price and Forecast - CNN
Tempus Ai Inc Stock (TEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.73%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):